VB10.2129
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VB10.2129, covering 2024-04-11 to 2024-04-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers [Phase 1, Phase 2]